High-dose vitamin C to enhance neoadjuvant immune checkpoint therapy in mismatch repair proficient colon cancer: The ALFEO pilot study.

Authors

Andrea Sartore-Bianchi

Andrea Sartore-Bianchi

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy & Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy

Andrea Sartore-Bianchi , Alessio Amatu , Federica Di Nicolantonio , Teresa Troiani , Federica Tosi , Stefania Napolitano , Giulia Martini , Katia Bencardino , Erica Bonazzina , Pietro Carnevali , Edoardo Forti , Massimo Mutignani , Angelo Vanzulli , Silvia Ghezzi , Francesco Scaglione , Silvia Marsoni , Alberto Bardelli , Fortunato Ciardiello , Giovanni Ferrari , Salvatore Siena

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Combinations

Clinical Trial Registration Number

2022-502101-15-00

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS2675)

DOI

10.1200/JCO.2023.41.16_suppl.TPS2675

Abstract #

TPS2675

Poster Bd #

511a

Abstract Disclosures

Similar Posters

First Author: Yara L. Verschoor

First Author: Milton Jose De Barros E Silva

First Author: Sabine Breukers